Yanmei Zhong

680 citations
20 papers · 562 indexed · h-index 12

Yanmei Zhong

20 papers receiving 559 citations

Peers

Yanmei Zhong
Comparison fields: 5 of 78
  • Cancer Research 98
  • Oncology 121
  • Molecular Biology 272
  • Pharmacology 34
  • Pulmonary and Respiratory Medicine 119
Replace Veena Somasundaram with:
Veena Somasundaram United States
Song Yi Bae South Korea
Eli Oldham United States
Katarzyna Brodowska United States
Mahdi Vasheghani Farahani Iran
Yiqun Xia China
Haonan Li China
Seyed Omid Sharifzadeh Iran
Xinzhi Huang China
Yanmei Zhong relative to Veena Somasundaram United States Veena Somasundaram's profile →
Citations per field
00.5×1.5×2.3×
Veena Somasundaram · 1×
Citations per year

Countries citing papers authored by Yanmei Zhong

Since Specialization
Citations

This map shows the geographic impact of Yanmei Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanmei Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanmei Zhong more than expected).

Fields of papers citing papers by Yanmei Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanmei Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanmei Zhong. The network helps show where Yanmei Zhong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yanmei Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yanmei Zhong Line = papers co-authored together Yanmei Zhong links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20246
2 20238
3 202311
4 202222
5 2021148
6 202129
7 202133
8 2021108
9 202018
10 202061
11 20184
12 201711
13 20178
14 201716
15 201710
16 201638
17 20165
18 201413
19
[Rapid identification and preliminary study of fragmentation regularity of saponins components of ginseng].
20135
20 20108

About Yanmei Zhong

Yanmei Zhong is a scholar working on Complementary and alternative medicine, Pharmacology and Physiology, having authored 20 papers that have together received 562 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (4 papers), Ginseng Biological Effects and Applications (3 papers), Traditional Chinese Medicine Analysis (3 papers), Ferroptosis and cancer prognosis (3 papers), RNA modifications and cancer (3 papers), Extracellular vesicles in disease (2 papers), Epigenetics and DNA Methylation (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Cancer Research (98 citations), Oncology (121 citations) and Molecular Biology (272 citations). Yanmei Zhong has collaborated with scholars based in China and United States. Frequent co-authors include Zong‐Wan Mao, Cai‐Ping Tan, Yu‐Yi Ling, Zhiyuan Li, Liang‐Nian Ji, Wenjin Wang, Dan Wang, Hao Liang, Yi Wang and Renxing Zhong. Their work appears in journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026